Treat Group
Sustainable Therapeutics for Improving Animal, Human, and Environmental Welfare
Company Overview
Snapshot
Founded in September 2019 by Sahar Meiron and Dr. Hilik Marom, Treat Group operates with 1–10 employees. The company was recognized as one of the fastest-growing Israeli startups founded in 2020.
Business overview
Treat Group is dedicated to developing sustainable therapeutics that enhance the well-being of animals, humans, and the environment. The company focuses on advanced research, drawing inspiration from natural solutions to address medical and environmental challenges. Operating within the Health Tech & Life Sciences sector, Treat Group's core activities span biopharmaceutical, biotechnology, and veterinary applications, targeting markets in pharmaceuticals and pet care.
Strategic signal
In November 2020, Treat Group was highlighted as one of the 101 fastest-growing Israeli startups founded in 2020 by Startupill. This recognition signals early market validation and strong growth potential for the company's innovative approach to sustainable therapeutics, indicating investor interest in its R&D stage and future commercialization prospects.
Log in to access full profile ›Company Intelligence Q&A
- When was Treat Group founded?
- Treat Group was founded in September 2019.
- Who are the founders of Treat Group?
- Treat Group was founded by Sahar Meiron and Dr. Hilik Marom.
- What is Treat Group's primary focus?
- Treat Group focuses on creating sustainable therapeutics to improve the welfare of animals, humans, and the environment.
- What recognition did Treat Group receive in 2020?
- In November 2020, Treat Group was listed among the 101 fastest-growing Israeli startups founded in 2020 by Startupill.
- What is Treat Group's current product stage?
- Treat Group's products are currently in the R&D stage, focusing on advanced research to develop sustainable therapeutics for animal, human, and environmental welfare.